VALERIE DORN: Open Payments
NPI 1861511750 · SEBRING, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$489 in 20 payments from 10 companies in 2025. Trend: 2023 $277 · 2024 $308 · 2025 $489
Food & beverage: $489
| Company | Payments | Amount |
|---|---|---|
| Corcept Therapeutics | 4 | $175 |
| Novo Nordisk Inc | 4 | $73 |
| Exact Sciences Corporation | 2 | $53 |
| Amgen Inc. | 3 | $46 |
| AstraZeneca Pharmaceuticals LP | 2 | $31 |
| Merck Sharp & Dohme LLC | 1 | $27 |
| Abbott Laboratories | 1 | $24 |
| Otsuka America Pharmaceutical, Inc. | 1 | $23 |
| Novartis Pharmaceuticals Corporation | 1 | $22 |
| Lilly USA, LLC | 1 | $16 |
Products named: Korlym, The Cologuard Plus Collection Kit, Wegovy, AIRSUPRA, OTEZLA, GARDASIL 9, FREESTYLE LIBRE, REXULTI.
Industry payments across FL — which companies pay providers there.
